EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

17β-Estradiol Promotes Tumorigenicity Through an Autocrine AREG/EGFR Loop in ER-α-Positive Breast Cancer Cells

Sun Young Yoon, Yisun Jeong, Jai Min Ryu, Se Kyung Lee, Byung Joo Chae, Jonghan Yu, Seok Won Kim, Seok Jin Nam, Sangmin Kim iD, Jeong Eon Lee iD

Cells · 2025

DOI: 10.3390/cells14100703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Sun Young Yoon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Cancer Center, Samsung Medical Center, 81 Irwon-Ro, Gangnam-gu, Seoul 06351, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Amphiregulin, ErbB Receptors, Estradiol. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We previously reported that the level of EGFR expression is directly associated with the survival rate of estrogen receptor-positive (ER+) breast cancer patients. Here, we investigated how ER activation by 17β-estradiol (E2), the most potent form of estrogen, affects the expression or activity of EGFR or EGFR-related genes in ER+ breast cancer cells. As expected, E2 enhanced cell proliferation, the induction of S phase, and tumor growth in ER+ breast cancer models. E2 also increased the expression of secretory proteins, including amphiregulin (AREG), angiogenin, artemin, and CXCL16. We focused on AREG, which is a ligand of the epidermal growth factor receptor (EGFR). The levels of AREG expression were positively correlated with ESR1 expression. Our results also showed higher AREG mRNA expression levels in ER+ breast cancer cells than in ER- breast cancer cells. We treated ER+ breast cancer cells with lapatinib to inhibit the AREG/EGFR signaling pathway and then completely inhibited E2-induced cell proliferation and S-phase induction. Similar to the lapatinib treatment, cell proliferation, S-phase induction, cell migration, and tumor growth were suppressed by AREG knockdown. Taken together, we demonstrated that the induction of AREG by E2 contributes to EGFR activation, which then affects cell proliferation and tumor growth. Therefore, we suggest that AREG acts as an intermediary between EGFR and ER and targeting both ERs and EGFRs through combination therapy could prevent tumor progression in EGFR+ ER+ breast cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAmphiregulinErbB ReceptorsEstradiolEstrogen Receptor alphaAutocrine CommunicationCarcinogenesisHumansFemaleCell ProliferationCell Line, TumorAnimalsSignal TransductionCell MovementGene Expression Regulation, NeoplasticMiceMice, Nude

Stichwörter der Autor:innen

AREGEGFRERprognosistargeted therapy

Substanzen

AmphiregulinErbB ReceptorsEstradiolEstrogen Receptor alphaAREG protein, humanEGFR protein, human

Autor:innen und Institutionen

  • Department of Breast Cancer Center, Samsung Medical Center, 81 Irwon-Ro, Gangnam-gu, Seoul 06351, Republic of Korea.
  • Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, 81 Irwon-Ro, Gangnam-gu, Seoul 06355, Republic of Korea.
  • Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-gu, Seoul 06351, Republic of Korea.

ORCID-Profile: Sangmin Kim, Jeong Eon Lee

Förderung

  • National Research Foundation of Korea
  • Ministry of Education

Zitieren

APA

Yoon, S. Y., Jeong, Y., Ryu, J. M., Lee, S. K., Chae, B. J., Yu, J., Kim, S. W., Nam, S. J., Kim, S., & Lee, J. E. (2025). 17β-Estradiol Promotes Tumorigenicity Through an Autocrine AREG/EGFR Loop in ER-α-Positive Breast Cancer Cells. Cells. https://doi.org/10.3390/cells14100703

Vancouver

Yoon SY, Jeong Y, Ryu JM, Lee SK, Chae BJ, Yu J, et al. 17β-Estradiol Promotes Tumorigenicity Through an Autocrine AREG/EGFR Loop in ER-α-Positive Breast Cancer Cells. Cells. 2025. doi:10.3390/cells14100703

BibTeX
@article{Yoon2025,
  author = {Yoon, Sun Young and Jeong, Yisun and Ryu, Jai Min and Lee, Se Kyung and Chae, Byung Joo and Yu, Jonghan and Kim, Seok Won and Nam, Seok Jin and Kim, Sangmin and Lee, Jeong Eon},
  title = {17β-Estradiol Promotes Tumorigenicity Through an Autocrine AREG/EGFR Loop in ER-α-Positive Breast Cancer Cells},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14100703}
}
Kostenlos starten →